Analysts Viewpoint
A company insider recently sold 37,656 shares of CytomX Therapeutics Inc [CTMX]. Should You Sale?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CytomX Therapeutics
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
CytomX Therapeutics Inc’s recently made public that its CEO McCarthy Sean A. unloaded Company’s shares for reported $22556.0 on Mar